105 related articles for article (PubMed ID: 20505264)
1. HDAC inhibitor-mediated radiosensitization in human carcinoma cells: a general phenomenon?
Kim IA; Kim IH; Kim HJ; Chie EK; Kim JS
J Radiat Res; 2010; 51(3):257-63. PubMed ID: 20505264
[TBL] [Abstract][Full Text] [Related]
2. Histone deacetylase inhibitor-mediated radiosensitization of human cancer cells: class differences and the potential influence of p53.
Kim IA; Shin JH; Kim IH; Kim JH; Kim JS; Wu HG; Chie EK; Ha SW; Park CI; Kao GD
Clin Cancer Res; 2006 Feb; 12(3 Pt 1):940-9. PubMed ID: 16467109
[TBL] [Abstract][Full Text] [Related]
3. Sensitization to gamma-irradiation-induced cell cycle arrest and apoptosis by the histone deacetylase inhibitor trichostatin A in non-small cell lung cancer (NSCLC) cells.
Zhang F; Zhang T; Teng ZH; Zhang R; Wang JB; Mei QB
Cancer Biol Ther; 2009 May; 8(9):823-31. PubMed ID: 19270532
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of radiation sensitivity of human squamous carcinoma cells by histone deacetylase inhibitors.
Zhang Y; Jung M; Dritschilo A; Jung M
Radiat Res; 2004 Jun; 161(6):667-74. PubMed ID: 15161353
[TBL] [Abstract][Full Text] [Related]
5. Radiosensitization by the histone deacetylase inhibitor PCI-24781.
Banuelos CA; Banáth JP; MacPhail SH; Zhao J; Reitsema T; Olive PL
Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6816-26. PubMed ID: 18006784
[TBL] [Abstract][Full Text] [Related]
6. Histone deacetylase inhibitors sensitize human non-small cell lung cancer cells to ionizing radiation through acetyl p53-mediated c-myc down-regulation.
Seo SK; Jin HO; Woo SH; Kim YS; An S; Lee JH; Hong SI; Lee KH; Choe TB; Park IC
J Thorac Oncol; 2011 Aug; 6(8):1313-9. PubMed ID: 21642861
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic modulation of radiation response in human cancer cells with activated EGFR or HER-2 signaling: potential role of histone deacetylase 6.
Kim IA; No M; Lee JM; Shin JH; Oh JS; Choi EJ; Kim IH; Atadja P; Bernhard EJ
Radiother Oncol; 2009 Jul; 92(1):125-32. PubMed ID: 19329208
[TBL] [Abstract][Full Text] [Related]
8. Regulation of radiosensitivity by HDAC inhibitor trichostatin A in the human cervical carcinoma cell line Hela.
Yu J; Mi J; Wang Y; Wang A; Tian X
Eur J Gynaecol Oncol; 2012; 33(3):285-90. PubMed ID: 22873101
[TBL] [Abstract][Full Text] [Related]
9. Trichostatin A increases radiosensitization of tongue squamous cell carcinoma via miR‑375.
Jia L; Zhang S; Huang Y; Zheng Y; Gan Y
Oncol Rep; 2017 Jan; 37(1):305-312. PubMed ID: 27878285
[TBL] [Abstract][Full Text] [Related]
10. Scriptaid, a novel histone deacetylase inhibitor, enhances the response of human tumor cells to radiation.
Kuribayashi T; Ohara M; Sora S; Kubota N
Int J Mol Med; 2010 Jan; 25(1):25-9. PubMed ID: 19956898
[TBL] [Abstract][Full Text] [Related]
11. Susceptibility and radiosensitization of human glioblastoma cells to trichostatin A, a histone deacetylase inhibitor.
Kim JH; Shin JH; Kim IH
Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):1174-80. PubMed ID: 15234053
[TBL] [Abstract][Full Text] [Related]
12. Is level of acetylation directly correlated to radiation sensitivity of cancer cell?
Zhang F; Chen Z; Shao C; Huang Q
Mutat Res; 2019 Jan; 813():13-19. PubMed ID: 30576946
[TBL] [Abstract][Full Text] [Related]
13. Radiosensitization of colorectal carcinoma cell lines by histone deacetylase inhibition.
Flatmark K; Nome RV; Folkvord S; Bratland A; Rasmussen H; Ellefsen MS; Fodstad Ø; Ree AH
Radiat Oncol; 2006 Aug; 1():25. PubMed ID: 16887021
[TBL] [Abstract][Full Text] [Related]
14. Phenylbutyrate sensitizes human glioblastoma cells lacking wild-type p53 function to ionizing radiation.
Lopez CA; Feng FY; Herman JM; Nyati MK; Lawrence TS; Ljungman M
Int J Radiat Oncol Biol Phys; 2007 Sep; 69(1):214-20. PubMed ID: 17707275
[TBL] [Abstract][Full Text] [Related]
15. Radiosensitization by SAHA in experimental colorectal carcinoma models-in vivo effects and relevance of histone acetylation status.
Folkvord S; Ree AH; Furre T; Halvorsen T; Flatmark K
Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):546-52. PubMed ID: 19427556
[TBL] [Abstract][Full Text] [Related]
16. A systematic assessment of radiation dose enhancement by 5-Aza-2'-deoxycytidine and histone deacetylase inhibitors in head-and-neck squamous cell carcinoma.
De Schutter H; Kimpe M; Isebaert S; Nuyts S
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):904-12. PubMed ID: 19215824
[TBL] [Abstract][Full Text] [Related]
17. Histone deacetylase inhibitors induce cell death and enhance the susceptibility to ionizing radiation, etoposide, and TRAIL in medulloblastoma cells.
Sonnemann J; Kumar KS; Heesch S; Müller C; Hartwig C; Maass M; Bader P; Beck JF
Int J Oncol; 2006 Mar; 28(3):755-66. PubMed ID: 16465382
[TBL] [Abstract][Full Text] [Related]
18. Histone deacetylase inhibition decreases proliferation and potentiates the effect of ionizing radiation in atypical teratoid/rhabdoid tumor cells.
Knipstein JA; Birks DK; Donson AM; Alimova I; Foreman NK; Vibhakar R
Neuro Oncol; 2012 Feb; 14(2):175-83. PubMed ID: 22156471
[TBL] [Abstract][Full Text] [Related]
19. Cisplatin-mediated radiosensitization of non-small cell lung cancer cells is stimulated by ATM inhibition.
Toulany M; Mihatsch J; Holler M; Chaachouay H; Rodemann HP
Radiother Oncol; 2014 May; 111(2):228-36. PubMed ID: 24857596
[TBL] [Abstract][Full Text] [Related]
20. The novel HDAC inhibitor NDACI054 sensitizes human cancer cells to radiotherapy.
Hehlgans S; Storch K; Lange I; Cordes N
Radiother Oncol; 2013 Oct; 109(1):126-32. PubMed ID: 24060178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
